Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

☰

Fast-Growing Intarcia Awaits Crucial FDA Decision in New Boston HQ

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-scientist5.jpg" NAME"Fast-Growing Intarcia Awaits Crucial FDA Decision in New Boston HQ" ALT"Fast-Growing Intarcia Awaits Crucial FDA Decision in New Boston HQ"May 8, 2017By Mark Terry, BioSpace.com Breaking News Staff...…

Continue ReadingFast-Growing Intarcia Awaits Crucial FDA Decision in New Boston HQ

AstraZeneca Canada Release: Pan-Canadian Oncology Drug Review Recommendation Supports The Use Of Tagrisso (Osimertinib) As The Standard Of Care For T790M Mutated Non-Small Cell Lung Cancer

  • Post author:
  • Post category:BioPharma

  Life Sciences Jobs   ... Source: BioSpace

Continue ReadingAstraZeneca Canada Release: Pan-Canadian Oncology Drug Review Recommendation Supports The Use Of Tagrisso (Osimertinib) As The Standard Of Care For T790M Mutated Non-Small Cell Lung Cancer